Our Science

We pioneered the discovery of DAP10/12 co-stimulatory and signaling domains to improve CAR T-cell efficacy and prevent exhaustion by tonic signaling, a common cause of manufacturing failure. Our platform is applicable to autologous and allogeneic technology, addressing hematological malignancies, solid tumors, and non-oncologic applications.

Learn about Our Science